Asset Details
Do you wish to reserve the book?
E-046 Traumatic subdural hematoma outcomes in American prisoners following surgical decompression
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
E-046 Traumatic subdural hematoma outcomes in American prisoners following surgical decompression
Do you wish to request the book?
E-046 Traumatic subdural hematoma outcomes in American prisoners following surgical decompression
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
E-046 Traumatic subdural hematoma outcomes in American prisoners following surgical decompression
2025
Overview
IntroductionThere are over 2.2 million Americans who are incarcerated and are known to have disproportionately poor healthcare access and health outcomes. Incarcerated patients are less likely to receive surgery for traumatic subdural hematomas (tSDHs) when compared to the general population, yet post-operative outcomes remain unknown.MethodsThis study used the National Inpatient Sample (NIS) database to identify patients surgically treated for tSDH from 2016 to 2021. Patients were stratified by incarceration status. Demographic information, including race, sex, and region, was collected for all patients. Multivariate logistic regression was then used to identify predictors of outcomes, including mortality, complications, length of stay (LOS), and total cost of care.ResultsWe analyzed 146,095 admissions for patients surgically treated for tSDH, 245 (0.168%) of whom were incarcerated. Incarcerated individuals did not experience a difference in in-hospital mortality rate compared to the public (18.7% versus 15.7%, p=0.565), nor a longer LOS (10.7 versus 10.0 days, p=0.676). Incarcerated patients were more likely to suffer any form of complication (57.1%, p=0.035), incur a higher estimated cost of care ( $58,636, SD $ 53,120, p=0.046), and be routinely discharged (58.3% versus 24.6%, p<0.001).ConclusionDespite having an equal LOS and in-hospital mortality rate, incarcerated individuals with tSDH face a higher risk of complications and increased care costs compared to non-incarcerated patients.DisclosuresJ. Chen: None. A. Gajjar: None. D. Dwivedi: None. M. Caine: None. N. Ramachandran: None. A. Paul: None.
Publisher
BMJ Publishing Group LTD
Subject
